Xvivo Perfusion AB (XVIVO) — Cash Flow Quality Index
Xvivo Perfusion AB (XVIVO) has a Cash Flow Quality Index of 1.53x as of March 2026. Operating cash flow of Skr65.34 Million exceeds net income of Skr42.83 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Xvivo Perfusion AB to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xvivo Perfusion AB Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Xvivo Perfusion AB across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Xvivo Perfusion AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Xvivo Perfusion AB (2012–2025)
Year-by-year earnings quality comparison for Xvivo Perfusion AB. For live market cap and the full company financial profile, see Xvivo Perfusion AB market capitalisation.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.02x | Skr101.07 Million | Skr25.16 Million | ▲ +621.6% |
| 2024 | 0.56x | Skr111.29 Million | Skr199.95 Million | ▲ +10.4% |
| 2023 | 0.50x | Skr46.29 Million | Skr91.82 Million | ▼ -59.6% |
| 2022 | 1.25x | Skr27.86 Million | Skr22.31 Million | ▲ +169.0% |
| 2021 | -1.81x | Skr-12.06 Million | Skr6.67 Million | ▼ -132.4% |
| 2019 | 5.58x | Skr29.50 Million | Skr5.29 Million | ▲ +313.0% |
| 2018 | 1.35x | Skr23.63 Million | Skr17.50 Million | ▼ -54.7% |
| 2017 | 2.98x | Skr22.19 Million | Skr7.45 Million | ▼ -29.0% |
| 2016 | 4.19x | Skr12.55 Million | Skr2.99 Million | ▲ +261.6% |
| 2015 | 1.16x | Skr8.58 Million | Skr7.40 Million | ▲ +308.2% |
| 2014 | -0.56x | Skr-3.74 Million | Skr6.72 Million | ▼ -144.3% |
| 2013 | 1.26x | Skr13.46 Million | Skr10.72 Million | ▼ -89.5% |
| 2012 | 12.01x | Skr1.67 Million | Skr139.00K | — |